Perfint Healthcare Pvt Ltd, a Chennai-based manufacturer of equipment for imaged-guided, minimally invasive equipment for cancer treatment, has received a $11-million (Rs 60 crore) additional funding from one of its investors.
S. Nandakumar, Chief Executive Officer, Perfint Healthcare, told media persons that Norwest Venture Partners, a global venture and growth equity firm, has invested to support the company’s plans to commercialise an equipment, Maxio, that will enable doctors visualise, plan and operate the robotic targeting system, using CT Scan images, to destroy a tumour.
The robotic system can precisely place multiple needles on the tumour site to apply the required energy -- microwave, radiofrequency, laser or a cryogenic material – or other material to kill the tumour.
Perfint has developed the equipment, tested the prototypes and is set to commercialise the product.
With the funds from Norwest, the company also hopes to develop similar equipment that will use ultrasound image for the guided procedure, expand its market in the US, China and Japan where regulatory approvals are awaited and set up and expand its advanced technology lab in the US, Nandakumar said.